-
Loading metrics
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity
-
Thomas W. von Geldern ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
* E-mail: thomas.vongeldern@abbvie.com, tvongeldern@earthlink.net
Affiliations Global Pharmaceutical Research and Development, AbbVie, North Chicago, Illinois, United States of America, Franciscan Institute for World Health, Franciscan University, Steubenville, Ohio, United States of America
⨯ - Howard E. Morton,
- Rick F. Clark,
- Brian S. Brown,
- Kelly L. Johnston,
-
Louise Ford,
Roles Data curation, Investigation, Methodology, Writing – review & editing
Affiliation Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
⨯ - Sabine Specht,
- Robert A. Carr,
- Deanne F. Stolarik,
-
Junli Ma,
Roles Investigation, Methodology
Affiliation Global Pharmaceutical Research and Development, AbbVie, North Chicago, Illinois, United States of America
⨯ - Matthew J. Rieser,
- Dominique Struever,
- Stefan J. Frohberger,
- Marianne Koschel,
- Alexandra Ehrens,
- Joseph D. Turner,
- Marc P. Hübner,
- Achim Hoerauf,
- Mark J. Taylor,
- Stephen A. Ward,
- Kennan Marsh,
- [ ... ],
- Dale J. Kempf
- [ view all ]
- [ view less ]
http://orcid.org/0000-0002-0649-7885
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity
- Thomas W. von Geldern,
- Howard E. Morton,
- Rick F. Clark,
- Brian S. Brown,
- Kelly L. Johnston,
- Louise Ford,
- Sabine Specht,
- Robert A. Carr,
- Deanne F. Stolarik,
- Junli Ma
-
- Published: February 28, 2019
- https://doi.org/10.1371/journal.pntd.0007159